Welcome to QOL Medical, LLC

QOL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.

QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underserved markets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.

QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.

Updated Notification 7/9/15:
Immediate Action Required For All Sucraid® Refills And New Prescriptions After July 17, 2015.

Explore QOL’s Family of Products


Sucraid® (sacrosidase) Oral Solution

Click the link above to be directed to the Sucraid® website


Ethamolin® (Ethanolamine Oleate) Injection 5%

Click the link above to be directed to the Ethamolin® website

© QOL Medical. All Rights Reserved. Terms of Use | Privacy Policy